Mo1857 - Vedolizumab Levels During Induction are Associated with Long-Term Clinical and Endoscopic Remission in Patients with Inflammatory Bowel Disease — Andrés Yarur (2018) | RDL Network
Mo1857 - Vedolizumab Levels During Induction are Associated with Long-Term Clinical and Endoscopic Remission in Patients with Inflammatory Bowel Disease
Andrés Yarur, Alexandra Bruss, Snehal Naik, Poonam Beniwal‐Patel, Caroline S. Fox, Anjali Jain, Brandon Berens, Amir Patel, Ryan C. Ungaro, Bayda Bahur, Marla Dubinsky, Dan Joseph Stein
Andrés Yarur, Alexandra Bruss, Snehal Naik, Poonam Beniwal‐Patel, Caroline S. Fox, Anjali Jain, Brandon Berens, Amir Patel, Ryan C. Ungaro, Bayda Bahur, Marla C. Dubinsky, Dan Joseph Stein
Ryan C. Ungaro, Andrés Yarur, Jacqueline Jossen, Becky L. Phan, Ezra Chefitz, Priya Sehgal, Kanika Kamal, Alexandra Bruss, Poonam Beniwal‐Patel, Caroline S. Fox, Amir Patel, Bayda Bahur, Anjali Jain, Dan Joseph Stein, Snehal Naik, Marla C. Dubinsky
Discussion(0)
No comments yet. Be the first to comment.